Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria R Parkhurst

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Antigen Experienced T Cells from Peripheral Blood Recognize p53 NeoantigensParisa Malekzadeh, Rami Yossef, Gal Cafri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitisMaria R Parkhurst, James C Yang, Russell C Langan, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.
Cancer Cell|December 1, 2023
Phenotypic signatures of circulating neoantigen-reactive CD8<sup>+</sup> T cells in patients with metastatic cancersRami Yossef, Sri Krishna, Sivasish Sindiri, et al.
Cancer Discovery|June 6, 2019
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersMaria R Parkhurst, Paul F Robbins, Eric Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.
Nature Medicine|April 1, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Antigen Experienced T Cells from Peripheral Blood Recognize p53 NeoantigensParisa Malekzadeh, Rami Yossef, Gal Cafri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitisMaria R Parkhurst, James C Yang, Russell C Langan, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.
Cancer Cell|December 1, 2023
Phenotypic signatures of circulating neoantigen-reactive CD8<sup>+</sup> T cells in patients with metastatic cancersRami Yossef, Sri Krishna, Sivasish Sindiri, et al.
Cancer Discovery|June 6, 2019
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersMaria R Parkhurst, Paul F Robbins, Eric Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.
Nature Medicine|April 1, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.
Pageof 4